Qin Xie
Directeur/Bestuurslid bij CUTIA THERAPEUTICS
Profiel
Qin Xie is currently a Director at Cutia Therapeutics (Shanghai) Co., Ltd.
and a Non-Executive Director at Cutia Therapeutics.
Previously, Dr. Xie held positions as a Managing Director at Frontline Bioventures, a Senior Investment Manager at Shanghai Pharmaceuticals Holding Co., Ltd., a Manager-Business Development at Hisun Pfizer Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at Ocumension Therapeutics.
Dr. Xie completed a graduate degree at the University of Oxford in 2004, a doctorate degree at the University of Oxford in 2011, and an undergraduate degree at Xi'an Jiaotong University in 2003.
Actieve functies van Qin Xie
| Bedrijven | Functie | Begin |
|---|---|---|
| CUTIA THERAPEUTICS | Directeur/Bestuurslid | 23-08-2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Qin Xie
| Bedrijven | Functie | Einde |
|---|---|---|
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Corporate Officer/Principal | 01-12-2015 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Chief Investment Officer | 01-12-2012 |
| Frontline Bioventures | Algemeen Directeur | - |
| OCUMENSION THERAPEUTICS | Directeur/Bestuurslid | - |
Opleiding van Qin Xie
| University of Oxford | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Health Technology |
| CUTIA THERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Frontline Bioventures | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Health Technology |
